Shenzhen Bioeasy Biotechnology Co., Ltd. (SHE:300942)
China
· Delayed Price · Currency is CNY 7.93
+0.04 (0.51%)
Apr 30, 2026, 11:54 AM CST
SHE:300942 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Cash & Equivalents | 412.01 | 392.84 | 293.4 | 481.75 | 247.45 | 342.21 | Upgrade
|
| Short-Term Investments | - | - | - | - | 181.91 | - | Upgrade
|
| Trading Asset Securities | 187.64 | 235.3 | 302.92 | 120.03 | - | 340.21 | Upgrade
|
| Cash & Short-Term Investments | 599.66 | 628.13 | 596.31 | 601.78 | 429.36 | 682.42 | Upgrade
|
| Cash Growth | 3.12% | 5.34% | -0.91% | 40.16% | -37.08% | 80.01% | Upgrade
|
| Accounts Receivable | 102.74 | 111.33 | 94.11 | 76.2 | 84.03 | 97.37 | Upgrade
|
| Other Receivables | 5.12 | 4.4 | 2.12 | 3.36 | 15.17 | 6.5 | Upgrade
|
| Receivables | 107.86 | 115.74 | 96.23 | 79.56 | 99.2 | 103.87 | Upgrade
|
| Inventory | 62.28 | 54.77 | 40.43 | 31.46 | 100.61 | 93.86 | Upgrade
|
| Other Current Assets | 28.46 | 19.17 | 18.64 | 24.87 | 45.25 | 17.49 | Upgrade
|
| Total Current Assets | 798.26 | 817.81 | 751.62 | 737.67 | 674.42 | 897.64 | Upgrade
|
| Property, Plant & Equipment | 572.05 | 578.27 | 562.9 | 426.52 | 324.64 | 143.44 | Upgrade
|
| Long-Term Investments | 69.92 | 83.52 | 100.69 | 145.18 | 195.76 | 21.94 | Upgrade
|
| Other Intangible Assets | 36.86 | 37.35 | 39.24 | 41.39 | 42.4 | 42.6 | Upgrade
|
| Long-Term Accounts Receivable | - | - | - | - | 3.61 | - | Upgrade
|
| Long-Term Deferred Tax Assets | 9.74 | 7.05 | 0.08 | 3.06 | 14.9 | 7.4 | Upgrade
|
| Long-Term Deferred Charges | 1.14 | 0.54 | 1.68 | 1.93 | 14.3 | 11.42 | Upgrade
|
| Other Long-Term Assets | - | - | 0.96 | 0.59 | 12.42 | 28.07 | Upgrade
|
| Total Assets | 1,488 | 1,525 | 1,457 | 1,356 | 1,282 | 1,153 | Upgrade
|
| Accounts Payable | 44.77 | 72.96 | 58.76 | 77.35 | 65.11 | 55.66 | Upgrade
|
| Accrued Expenses | 15.61 | 21.59 | 23.08 | 23.94 | 39.45 | 46.73 | Upgrade
|
| Short-Term Debt | 11 | 21 | - | - | - | - | Upgrade
|
| Current Portion of Long-Term Debt | 13.98 | 13.55 | 41.6 | 5.47 | 5.18 | - | Upgrade
|
| Current Portion of Leases | - | - | - | 9.28 | 18.6 | 14 | Upgrade
|
| Current Income Taxes Payable | 3.72 | 5.6 | 0.05 | 0.01 | 0.01 | 9.74 | Upgrade
|
| Current Unearned Revenue | 14.18 | 17.18 | 25.1 | 18.65 | 66.61 | 27.59 | Upgrade
|
| Other Current Liabilities | 6.21 | 8.83 | 3.36 | 2.22 | 4.82 | 2.91 | Upgrade
|
| Total Current Liabilities | 109.46 | 160.7 | 151.96 | 136.93 | 199.78 | 156.63 | Upgrade
|
| Long-Term Debt | 436.51 | 413 | 426.39 | 345.78 | 56.32 | - | Upgrade
|
| Long-Term Leases | - | - | - | 5.34 | 39.25 | 27.12 | Upgrade
|
| Long-Term Unearned Revenue | 40.5 | 41.09 | 6.5 | 16.54 | 20.33 | 22.19 | Upgrade
|
| Other Long-Term Liabilities | 2.08 | 2.08 | 2.08 | 3.02 | 2.08 | - | Upgrade
|
| Total Liabilities | 588.54 | 616.87 | 586.92 | 507.61 | 317.75 | 205.94 | Upgrade
|
| Common Stock | 405.07 | 405.07 | 401.32 | 400.86 | 400.86 | 400.86 | Upgrade
|
| Additional Paid-In Capital | 221.58 | 221.56 | 190.22 | 186.59 | 178.7 | 141.91 | Upgrade
|
| Retained Earnings | 205.63 | 215.89 | 209.14 | 192.02 | 385.43 | 402.28 | Upgrade
|
| Comprehensive Income & Other | 61.34 | 61.56 | 68.33 | 69.52 | -0.09 | -0.28 | Upgrade
|
| Total Common Equity | 893.62 | 904.08 | 869.01 | 848.99 | 964.89 | 944.76 | Upgrade
|
| Minority Interest | 5.8 | 3.6 | 1.24 | -0.27 | -0.19 | 1.82 | Upgrade
|
| Shareholders' Equity | 899.42 | 907.68 | 870.24 | 848.73 | 964.7 | 946.58 | Upgrade
|
| Total Liabilities & Equity | 1,488 | 1,525 | 1,457 | 1,356 | 1,282 | 1,153 | Upgrade
|
| Total Debt | 461.49 | 447.55 | 467.98 | 365.87 | 119.34 | 41.12 | Upgrade
|
| Net Cash (Debt) | 138.17 | 180.59 | 128.33 | 235.91 | 310.02 | 641.31 | Upgrade
|
| Net Cash Growth | 30.42% | 40.72% | -45.60% | -23.91% | -51.66% | 69.17% | Upgrade
|
| Net Cash Per Share | 0.30 | 0.39 | 0.30 | 0.59 | 0.78 | 1.63 | Upgrade
|
| Filing Date Shares Outstanding | 405.51 | 628.23 | 401.32 | 400.86 | 400.86 | 400.86 | Upgrade
|
| Total Common Shares Outstanding | 405.51 | 628.23 | 401.32 | 400.86 | 400.86 | 400.86 | Upgrade
|
| Working Capital | 688.8 | 657.11 | 599.66 | 600.74 | 474.64 | 741.02 | Upgrade
|
| Book Value Per Share | 2.20 | 1.44 | 2.17 | 2.12 | 2.41 | 2.36 | Upgrade
|
| Tangible Book Value | 856.76 | 866.73 | 829.76 | 807.6 | 922.49 | 902.16 | Upgrade
|
| Tangible Book Value Per Share | 2.11 | 1.38 | 2.07 | 2.01 | 2.30 | 2.25 | Upgrade
|
| Buildings | - | - | 330.03 | 15.87 | 15.87 | 10.24 | Upgrade
|
| Machinery | - | - | 87.09 | 90.58 | 106.51 | 72.08 | Upgrade
|
| Construction In Progress | - | - | 199.79 | 356.63 | 190.87 | 51.34 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.